Loading clinical trials...
Loading clinical trials...
Assessment of Tumor Resistance and Stem Cells in Prostate Cancer
The primary objective of this study is to collect material for study's to assess mechanisms of tumor progression, mechanisms of resistance, isolation of stem cells and biologic markers in tissue, serum and peripheral blood mononuclear cells.
Age
18 - No limit years
Sex
MALE
Healthy Volunteers
No
Rutgers Cancer Institute of New Jersey
New Brunswick, New Jersey, United States
Start Date
December 12, 2008
Primary Completion Date
April 10, 2017
Completion Date
April 10, 2017
Last Updated
April 8, 2021
126
ACTUAL participants
Lead Sponsor
Rutgers, The State University of New Jersey
Collaborators
NCT05691465
NCT06842498
Data Source & Attribution
This clinical trial information is sourced from ClinicalTrials.gov, a service of the U.S. National Institutes of Health.
Modifications: This data has been reformatted for display purposes. Eligibility criteria have been parsed into inclusion/exclusion sections. Location data has been geocoded to enable distance-based search. For the authoritative and most current information, please visit ClinicalTrials.gov.
Neither the United States Government nor Clareo Health make any warranties regarding the data. Check ClinicalTrials.gov frequently for updates.
View ClinicalTrials.gov Terms and ConditionsNCT04550494